Early serial circulating tumor DNA sequencing predicts the efficacy of chemohormonal therapy in patients with metastatic hormone-sensitive prostate cancerXinxing Du, Baijun Dong, Liancheng Fan et al.|Translational Oncology|2023Cited by 8
PD-1 inhibitor plus anlotinib for metastatic castration-resistant prostate cancer: a real-world studyXinxing Du, Wei Xue, Yan-Hao Dong et al.|Asian Journal of Andrology|2022Cited by 5